Year archive

AprilBio Co.,Ltd. — 2026 filings

All 24 regulatory filings released by AprilBio Co.,Ltd. (397030) in 2026, sourced directly from the official regulator.

24 Filings

2026 Period

2026 filings (24)

Filing	Released	Lang
분기보고서 (2026.03) Interim / Quarterly Report Q1 2026	2026-05-15	Korean
투자판단관련주요경영사항 (유한양행, SAFA 기반 융합단백질 기술라이선스 및 공동연구개발 계약 조기 종료) Regulatory Filings	2026-05-04	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-04-16	Korean
주식등의대량보유상황보고서(약식) Major Shareholding Notification	2026-04-09	Korean
정기주주총회결과 Declaration of Voting Results & Voting Rights Announcements	2026-03-25	Korean
감사보고서제출 Audit Report / Information FY 2025	2026-03-13	Korean
사업보고서 (2025.12) Audit Report / Information FY 2025	2026-03-13	Korean
주주총회소집공고 Proxy Solicitation & Information Statement	2026-03-10	Korean
의결권대리행사권유참고서류 Proxy Solicitation & Information Statement	2026-03-10	Korean
[기재정정]주주총회소집결의 Proxy Solicitation & Information Statement	2026-03-06	Korean
주주총회집중일개최사유신고 AGM Information	2026-03-03	Korean
주주총회소집결의 Proxy Solicitation & Information Statement	2026-03-03	Korean
기업설명회(IR)개최 Investor Presentation	2026-02-19	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-02-10	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-02-10	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-02-10	Korean
매출액또는손익구조30%(대규모법인은15%)이상변동 Management Reports	2026-02-09	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-16	Korean
임원ㆍ주요주주특정증권등소유상황보고서 Director's Dealing	2026-01-16	Korean